Fitch has adjusted its mid-year outlook for the port sectors in North America and EMEA to ‘deteriorating’ due to higher vulnerability to tariff-induced pressures, while APAC and Latin American port sectors maintain a ‘neutral’ outlook.

Fitch Ratings’ Global Government-Related Entities (GRE) Data Comparator shows Asian entities receive stronger government support, decision-making control, and oversight than global peers.

The credit outlook for global corporates has worsened in 2025, with 14 sectors and sub-sectors deteriorating at mid-year vs. 5 at end-2024. Justin Patrie and Carla Taylor, Head of Research for the Americas, discuss the drivers and implications.

Fitch has revised the 2025 global sovereigns outlook to ‘deteriorating’ from ‘neutral’, reflecting the increase in tariffs and policy uncertainty, which will weaken the global growth outlook and heighten the risk of more testing financing conditions.

This episode explores key changes and credit trends in China’s power sector, including renewables growth and market reforms. Insights from Penny Chen, Senior Director, Fitch Ratings, reveal what lies ahead for major power generators.

U.S. property/casualty (P/C) insurers’ recent premium rate hikes and surplus growth combined with beneficial legislative changes to the Florida market will better position (re)insurers to withstand the 2025 hurricane season.

In this video, our senior analyst explores the global ESG sukuk market, highlighting the recent market developments and share the ESG sukuk outlook for 2025-2026. Here is Amjad Alkabra on global ESG sukuk.

Paul Gamble, Senior Director of Sovereign Ratings, and Erich Arispe, Head of Emerging Europe Sovereign Ratings, discuss the credit implications and common themes of the 2025/2026 electoral cycle in Central and Eastern Europe.

中国人民银行继 5 月 9 日将 7 天期逆回购操作利率从 1.5% 下调至 1.4% 之后，今年可能会进一步降息。

Fitch has revised the 2025 sector outlooks for Global Medical Devices, Diagnostics & Products and Global Pharma & Biotech to deteriorating from neutral. The outlook for U.S. Healthcare Providers remains neutral.